Home

International Trade

The Global Biotech Industry Comes to BIO

The world’s largest biotech hubs are busy planning their delegations’ visits to the  BIO International Convention  next month. The international program at the Convention will be one of the most robust to date, with International Case Studies, breakout sessions focused on globalization and Super Sessions focused on the emerging markets.

Scientific American’s Worldview 2011 Preview

Scientific American will release the third annual Worldview: A Global Biotechnology Perspective at this year’s BIO International Convention.

Scientific American Worldview 2011 Preview -- New this year: Three pioneers share keys to success for building biotech in emerging markets

Three biotech luminaries who have succeeded against all odds share their experiences building a biotech company from the ground up in Brazil, China and India.

A Meating of Minds: Five Nations Voice Support for Livestock Cloning

Fifteen years after Dolly, the first mammal to be cloned from an adult cell rather than an embryo, made headlines, the process of livestock cloning is increasingly gaining acceptance as a viable means of satisfying demand for sustainable food production.

IP: Imperative for Innovation

Patent systems can provide an advantage to society by rewarding the development of new inventions, promoting the advancement of technology and protecting the investor.  Patents often are the most important, and sometimes only, asset of a biotech company. Patents and related rights must be obtained in a timely and predictable manner and the ability to enforce those patents is critical.

Bright Prospects: Biotech Execs Predict Continued Growth in 2011

Upward trends and investment opportunities will be focus of BIO’s World Congress in May.

Market Watch: Revamped Website Offers Agri-Biotech Product Info

Overhauled BIOTradeStatus lets users search for the latest information on hundreds of products.

New Heights: Report Shows Continued Growth of Biotech Crops

ISAAA data shows countries around the world have embraced agricultural biotechnology.

Innovation Wanted

Bringing biotechs into global health R&D.

BIO Poised to Partner with Chinese Leaders to Grow Biotech

This month, BIO is leading a delegation of biopharma CEOs to China for meetings with members of the Chinese biotech community and government leaders. The mission illustrates a strong commitment on behalf of the western biotechnology industry to encourage China to strengthen its support for biotech innovation and take steps to enhance greater investment and collaboration with companies in China. The series of meetings between China’s local industry and government leaders and biotech CEOs will lay the foundation for increased cooperation to help biotech flourish in China.

Will Your Worldview Change at the BIO International Convention?

Scientific American will release the third annual Worldview: A Global Biotechnology Perspective at this year’s BIO International Convention.  Created in partnership with BIO, the publication explores the diverse economic regions of the world, highlighting success stories, policy achievements, cutting-edge science and the unique challenges that lie ahead. This year’s report focuses on BRIC (Brazil, Russia, India and China) country efforts to build local biotechnology hubs. 

Intellectual Property in Emerging Markets

Brenda Herschbach Jarrell and Jennifer Groves present an overview of the IP landscape in China, India, Brazil and Korea.

How Has Europe Approached Biosimilars?

The European Medicines Agency (EMEA), the European equivalent to the Food and Drug Administration (FDA), has implemented an approval scheme that specifically distinguishes between biosimilars (follow-on biologics) and generic drugs.

The Biosafety Protocol-An Overview
Fernando Quesada Discusses Biotechnology in Mexico

Tracy Krughoff speaks with Fernando Quesada, executive director of the Biotechnology Center of Excellence Corporation, who is organizing Mexico’s participation in the BIO International Convention.

Letters, Testimony & Comments

BIO Comments on TTIP Negotiations
June 19 2013
The TTIP represents a profoundly important opportunity to advance progress in these areas. The following comments represent BIO’s initial suggestions for the formulation of negotiating objectives relevant to biotechnology.  
Transatlantic Trade and Investment Partnership
June 3 2013
BIO appreciates the opportunity to respond to the Request for Comments issued by the U.S. Trade Representative on objectives to be pursued in the negotiation of a Transatlantic Trade and Investment Partnership (TTIP) agreement. 
2013 Special 301 Submission: BIO Provides Input on Biotech IP Challenges Around the Globe
February 8 2013
Biotechnology companies provide unique benefits to the United States and the world. In the health care sector alone, the industry has developed and commercialized more than 300 biotechnology drugs and diagnostics and there are over 400 products in the pipeline.
BIO Comments on India Guidelines for Examining Biotechnology Applications
January 18 2013
The Biotechnology Industry Organization (BIO) appreciates the opportunity to provide comments in response to the Controller General of Patents Designs and Trademarks in India on the "Draft Guidelines for Examination of Biotechnology Applications" hereafter referred to as "Draft Guidelines", or "Guidelines".
India Traditional Knowledge and Biological Material Draft Guidelines: Biotech Industry Provides Input
November 28 2012
Given the importance of protections for basic biotechnology inventions to the survival of the biotechnology sector in India, BIO has reviewed the Guidelines and has identified specific questions, and areas for improvement.
More Letters, Testimony & Comments →

Press Releases

Intellectual Property Encourages Collaboration, R&D in Developing Economies
June 20 2012
The Biotechnology Industry Organization(BIO) unveiled a report on the role of intellectual property rights in encouraging upstream research and development as well as downstream commercialization of biotechnology at the 2012 BIO International Convention.
Scientific American to Host BIO International Convention Super Session to Release 4th Annual Worldview Report and Scorecard Highlighting Emerging Markets
June 6 2012
The report will be released at a Super Session, titled "International Leaders Share Their Worldview: Scientific American's Regional Bio-Innovation Scorecard."
BIO Urges U.S. Trade Representative to Preserve IP Protection Abroad
February 21 2011
The Biotechnology Industry Organization (BIO) stresses the critical importance of protecting intellectual property abroad in comments recently filed with the U.S. Trade Representative (USTR) on the 2011 Special 301 Review.
BIO Applauds Administration’s Progress in Brazilian Cotton Dispute
April 6 2010
The Obama Administration has made substantial progress to avoid retaliatory measures in a long-running “cotton dispute” brought by Brazil against the United States.
BIO Welcomes EU Decision on Biotech Crops
March 2 2010
The Biotechnology Industry Organization (BIO) applauded today’s announcement by the European Commission to authorize the cultivation of a biotech potato, as well as the commercialization of three varieties of biotech maize for food and feed uses and import and processing.
More Press Releases →